{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:33:49Z","timestamp":1787963629490,"version":"build-2784847793"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T00:00:00Z","timestamp":1324252800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0029144","type":"journal-article","created":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T16:58:11Z","timestamp":1324313891000},"page":"e29144","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Chromatin Remodeling, Cell Proliferation and Cell Death in Valproic Acid-Treated HeLa Cells"],"prefix":"10.1371","volume":"6","author":[{"given":"Marina Barreto","family":"Felisbino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wirla M. S. C.","family":"Tamashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza S.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,12,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogene.","volume":"276","author":"CJ Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1345\/aph.1K531","article-title":"Use of intravenous valproic acid for acute migraine.","volume":"42","author":"LA Frazee","year":"2008","journal-title":"Ann Pharmacother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review.","volume":"31","author":"MFB Silva","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0920-1211(02)00182-1","article-title":"Overtreatment in epilepsy: adverse consequences and mechanisms.","volume":"52","author":"E Perucca","year":"2002","journal-title":"Epilepsy Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.","volume":"20","author":"M G\u00f6ttlicher","year":"2001","journal-title":"Embo J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.0013-9580.2004.00104.x","article-title":"The activity of antiepileptic drugs as histone deacetylase inhibitors.","volume":"45","author":"S Eyal","year":"2004","journal-title":"Epilepsia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1158\/0008-5472.CAN-04-2478","article-title":"Valproic acid alters chromatin structure by regulation of chromatin modulation proteins.","volume":"65","author":"DC Marchion","year":"2005","journal-title":"Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1158\/1535-7163.MCT-08-1076","article-title":"Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo.","volume":"8","author":"MSQ Kortenhorst","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref9","first-page":"111","article-title":"Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.","volume":"39","author":"WS Fortson","year":"2011","journal-title":"Int J Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"art 17","DOI":"10.1186\/1756-8722-4-17","article-title":"Histone acetylases (HDACs) in XPC gene silencing and bladder cancer.","volume":"4","author":"XXS Xu","year":"2011","journal-title":"J Hematol Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.","volume":"409","author":"N Khan","year":"2008","journal-title":"Biochem J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1476-4598-7-70","article-title":"Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.","volume":"7","author":"M Dejligbjerg","year":"2008","journal-title":"Mol Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"27586","DOI":"10.1074\/jbc.M303740200","article-title":"Valproate induces replication-independent active DNA demethylation.","volume":"278","author":"N Detich","year":"2003","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/carcin\/bgl167","article-title":"Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes.","volume":"28","author":"S Milutinovic","year":"2007","journal-title":"Carcinogenesis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.neuropharm.2010.09.022","article-title":"Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons.","volume":"60","author":"Z Marinova","year":"2011","journal-title":"Neuropharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jb\/mvn074","article-title":"Valproic acid inhibits the growth of cervical cancer both <italic>in vitro<\/italic> and <italic>in vivo<\/italic>.","volume":"144","author":"S Sami","year":"2008","journal-title":"J Biochem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1742-7843.2011.00702.x","article-title":"The teratogenic potenties of valproic acid derivatives and their effects on biological end-points are related to change in histone deacetylase and Erk1\/2 activities.","volume":"109","author":"K Gotfryd","year":"2011","journal-title":"Basic & Clin Pharm Toxicol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1158\/1535-7163.MCT-05-0184","article-title":"Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC.","volume":"4","author":"XN Li","year":"2005","journal-title":"Mol Cancer Therap"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bjc.6603851","article-title":"Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial.","volume":"97","author":"A Atmaca","year":"2007","journal-title":"Br J Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1182\/blood-2007-03-078576","article-title":"Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodisplastic syndrome.","volume":"110","author":"AO Soriano","year":"2007","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1158\/1078-0432.CCR-08-1247","article-title":"Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers.","volume":"14","author":"F Braiteh","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/toxsci\/kfr070","article-title":"Short-time gene expression response to valproic acid analogs in mouse embryonic stem cells.","volume":"121","author":"M Jergil","year":"2011","journal-title":"Toxic Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1242\/jcs.01293","article-title":"Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin.","volume":"117","author":"KF T\u00f3th","year":"2004","journal-title":"J Cell Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbrc.2007.08.120","article-title":"Trichostatin-A induces differential changes in histone protein dynamics and expression in HeLa cells.","volume":"363","author":"J Rao","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1038\/sj.onc.1206502","article-title":"Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation.","volume":"22","author":"HJ Shin","year":"2003","journal-title":"Oncogene"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors.","volume":"5","author":"JE Bolden","year":"2006","journal-title":"Nature Rev Drug Discov"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action.","volume":"26","author":"WS Xu","year":"2007","journal-title":"Oncogene"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2007.11.002","article-title":"Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells.","volume":"365","author":"YH Gan","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"24420","DOI":"10.1074\/jbc.M802217200","article-title":"Acetylation of PML is involved in histone deacetylase inhibitor-mediator apoptosis.","volume":"283","author":"F Hayakawa","year":"2008","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1158\/1541-7786.MCR-08-0123","article-title":"Modulation of cyclin-dependent kinase inhibitor p21<sup>WAF1\/Cip1<\/sup> gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa cells.","volume":"6","author":"PY Liu","year":"2008","journal-title":"Mol Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2009.02.042","article-title":"Enhancing the apoptotic and therapeutic effects of HDAC inhibitors.","volume":"280","author":"AJ Frew","year":"2009","journal-title":"Cancer Lett"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbrc.2008.11.057","article-title":"An HDAC inhibitor, trichostatin A, induces a delay at G<sub>2<\/sub>\/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner.","volume":"378","author":"EJ Noh","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4149\/neo_2011_01_35","article-title":"Epigenetic modulation of gene expression of human leukemia cell lines \u2013 induction of cell death and senescence.","volume":"58","author":"K Elknerova","year":"2011","journal-title":"Neoplasma"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1768-322X.1984.tb00260.x","article-title":"Polyploidy and nuclear phenotypes in salivary glands of the rat.","volume":"50","author":"BC Vidal","year":"1984","journal-title":"Biol Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.micron.2009.02.010","article-title":"DNA content, chromatin supraorganization, nuclear glycoproteins and RNA amounts in hepatocytes of mice expressing insulin-dependent diabetes.","volume":"40","author":"MLS Mello","year":"2009","journal-title":"Micron"},{"key":"ref36","first-page":"255","article-title":"Human minisegregant cells.","author":"RT Johnson","year":"1978"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1139\/o90-151","article-title":"Image analysis of Feulgen-stained c-H-<italic>ras<\/italic>-transformed NIH\/3T3 cells.","volume":"68","author":"MLS Mello","year":"1990","journal-title":"Biochem Cell Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/excr.1995.1328","article-title":"Modulation of <italic>ras<\/italic> transformation affecting chromatin supraorganization as assessed by image analysis.","volume":"220","author":"MLS Mello","year":"1995","journal-title":"Expt Cell Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/excr.1998.4171","article-title":"DNA content and chromatin texture of benzo[a]pyrene-transformed human breast epithelial cells as assessed by image analysis.","volume":"244","author":"BC Vidal","year":"1998","journal-title":"Expt Cell Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/cyto.a.20113","article-title":"Chromatin supraorganization and extensibility following starvation and refeeding.","volume":"63","author":"AS Moraes","year":"2005","journal-title":"Cytometry Part A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cyto.a.20356","article-title":"Chromatin supraorganization and extensibility in mouse hepatocytes with development and aging.","volume":"71","author":"AS Moraes","year":"2007","journal-title":"Cytometry Part A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/1471-2407-8-291","article-title":"Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro.","volume":"8","author":"CML Machado","year":"2008","journal-title":"BMC Cancer"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1210\/en.2004-0877","article-title":"Valproic acid inhibits leptin secretion and reduces leptin messenger ribonucleic acid levels in adipocytes.","volume":"145","author":"DC Lagace","year":"2004","journal-title":"Endocrinology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1210\/en.2005-1030","article-title":"Suppression of adiponectin gene expression by histone deacetylase inhibitor valproic acid.","volume":"147","author":"LP Qiao","year":"2006","journal-title":"Endocrinology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neures.2009.05.002","article-title":"Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions.","volume":"65","author":"M Fukuchi","year":"2009","journal-title":"Neurosci Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/FPC.0b013e32830500a1","article-title":"Modest reactivation of the mutant FMR1 gene by valproic acid is accompanied by histone modifications but not DNA demethylation.","volume":"18","author":"E Tabolacci","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.taap.2010.08.001","article-title":"Epigenetic modifications in valproic acid-induced teratogenesis.","volume":"248","author":"EWY Tung","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF00368153","article-title":"Acid lability of deoxyribonucleic acids of some polytene chromosome regions of <italic>Rhynchosciara americana<\/italic>.","volume":"81","author":"MLS Mello","year":"1980","journal-title":"Chromosoma"},{"key":"ref49","first-page":"213","article-title":"Trichostatin A induces morphologic differentiation and inhibits growth in small cell lung cancer cells.","volume":"137","author":"CS Platta","year":"2007","journal-title":"J Surg Res"},{"key":"ref50","first-page":"510","article-title":"Cell nucleus pattern recognition: influence of staining.","volume":"17","author":"BC Vidal","year":"1973","journal-title":"Acta Cytol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1267\/ahc.27.23","article-title":"Image analysis: video system adequacy for the assortment of nuclear phenotypes based on chromatin texture evaluation.","volume":"27","author":"MLS Mello","year":"1994","journal-title":"Acta Histochem Cytochem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cdd.2008.150","article-title":"Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009.","volume":"16","author":"G Kroemer","year":"2009","journal-title":"Cell Death Differ"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0029144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T20:34:29Z","timestamp":1539981269000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0029144"}},"subtitle":[],"editor":[{"given":"Rakesh K.","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,19]]},"references-count":52,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0029144","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,19]]}}}